21-hydroxylase deficiency differential diagnosis: Difference between revisions
Line 21: | Line 21: | ||
|[[21-hydroxylase deficiency|Classic type of 21-hydroxylase deficiency]] | |[[21-hydroxylase deficiency|Classic type of 21-hydroxylase deficiency]] | ||
| | | | ||
* [[17- | * [[17-Hydroxyprogesterone|17-hydroxyprogesterone]] | ||
* [[Progesterone]] | * [[Progesterone]] | ||
* [[Androstenedione]] | * [[Androstenedione]] | ||
Line 28: | Line 28: | ||
* [[Aldosterone]] | * [[Aldosterone]] | ||
* [[Corticosterone]] (salt-wasting) | * [[Corticosterone]] (salt-wasting) | ||
* [[Cortisol]] (simple virilizing) | * [[Cortisol]] (simple [[virilizing]]) | ||
| | | | ||
* [[ | * [[Ambiguous genitalia]] in female | ||
* [[Virilization]] in female | * [[Virilization]] in female | ||
* Salt-wasting | * Salt-wasting | ||
Line 37: | Line 37: | ||
|[[11β-hydroxylase deficiency|11-β hydroxylase deficiency]] | |[[11β-hydroxylase deficiency|11-β hydroxylase deficiency]] | ||
| | | | ||
* | * [[Deoxycorticosterone]] | ||
* 11-Deoxy-cortisol | * 11-Deoxy-[[cortisol]] | ||
* [[17- | * [[17-Hydroxyprogesterone|17-hydroxyprogesterone]], mild elevation | ||
| | | | ||
* [[Cortisol]] | * [[Cortisol]] | ||
Line 45: | Line 45: | ||
* [[Aldosterone]] | * [[Aldosterone]] | ||
| | | | ||
* | * [[Ambiguous genitalia]] in female | ||
* Hypertension and hypokalemia | * [[Hypertension]] and [[hypokalemia]] | ||
*Virilization | * [[Virilization]] | ||
|- | |- | ||
|[[ | |[[17 alpha-hydroxylase deficiency|17-α hydroxylase deficiency]] | ||
| | | | ||
* | * [[Deoxycorticosterone]] | ||
* Corticosterone | * [[Corticosterone]] | ||
* Progesterone | * [[Progesterone]] | ||
| | | | ||
* Cortisol | * [[Cortisol]] | ||
* Aldosterone | * [[Aldosterone]] | ||
| | | | ||
* | * [[Ambiguous genitalia]] in male | ||
* Hypertension | * [[Hypertension]] | ||
* Primary amenorrhea | * [[Primary amenorrhea]] | ||
* Absence of secondary sexual characteristics | * Absence of [[secondary sexual characteristics]] | ||
* Minimal body hair | * Minimal [[body hair]] | ||
|- | |- | ||
|3β-Hydroxysteroid Dehydrogenase | |3β-Hydroxysteroid Dehydrogenase | ||
| | | | ||
* | * [[Dehydroepiandrosterone]] | ||
* 17- | * [[17-hydroxypregnenolone]] | ||
* Pregnenolone | * [[Pregnenolone]] | ||
| | | | ||
* Cortisol | * [[Cortisol]] | ||
* Aldosterone | * [[Aldosterone]] | ||
| | | | ||
* Vomiting, volume depletion, hyponatremia, and hyperkalemia | * [[Vomiting]], [[volume depletion]], [[hyponatremia]], and [[hyperkalemia]] | ||
* 46-XY infants often show undervirilization, due to a block in testosterone synthesis | * 46-XY infants often show [[undervirilization]], due to a block in [[testosterone]] synthesis | ||
|- | |- | ||
|Gestational hyperandrogenism | |Gestational [[hyperandrogenism]] | ||
| | | | ||
* Maternal serum androgen concentrations (usually testosterone and androstenedione) are high | * Maternal serum [[androgen]] concentrations (usually [[testosterone]] and [[androstenedione]]) are high | ||
* If virilization is caused by exogenous hormone administration, the values may be low because the offending hormone is usually a synthetic steroid not measured in assays for testosterone or other androgens | * If [[virilization]] is caused by exogenous hormone administration, the values may be low because the offending hormone is usually a synthetic [[steroid]] not measured in assays for [[testosterone]] or other [[androgens]] | ||
| | | | ||
| | | | ||
* Androgen excess sign and symptoms in mother | * [[Androgen]] excess sign and symptoms in mother | ||
* History of androgen containing medication consumption during pregnancy in mother | * History of [[androgen]] containing [[medication]] consumption during [[pregnancy]] in mother | ||
* Virilization in a 46,XX individual with normal female internal anatomy | * [[Virilization]] in a 46,XX individual with normal female internal anatomy | ||
* Causes include maternal luteoma or theca-lutein cysts, and placental aromatase enzyme deficiency | * Causes include maternal [[luteoma]] or theca-[[lutein]] [[cysts]], and [[placental]] [[aromatase]] enzyme deficiency | ||
|} | |} | ||
Line 101: | Line 101: | ||
|Non-classic type of 21-hydroxylase deficiency | |Non-classic type of 21-hydroxylase deficiency | ||
|Increased: | |Increased: | ||
* 17- | * [[17-Hydroxyprogesterone|17-hydroxyprogesterone]] | ||
* Exaggerated | * Exaggerated [[Androstenedione]], [[DHEA]], and [[17-Hydroxyprogesterone|17-hydroxyprogesterone]] | ||
response to ACTH | response to [[ACTH]] | ||
| | | | ||
* Low testosterone levels | * Low [[testosterone]] levels | ||
| | | | ||
* No symptoms in infancy and male | * No symptoms in infancy and male | ||
* Virilization in females | * [[Virilization]] in females | ||
|- | |- | ||
|[[ | |[[11β-hydroxylase deficiency|11-β hydroxylase deficiency]] | ||
|Increased: | |Increased: | ||
* DOC | * DOC | ||
* 11-Deoxy- | * 11-Deoxy-[[Cortisol]] | ||
Decreased: | Decreased: | ||
* Cortisol | * [[Cortisol]] | ||
* Corticosterone | * [[Corticosterone]] | ||
* Aldosterone | * [[Aldosterone]] | ||
| | | | ||
* Low testosterone levels | * Low [[testosterone]] levels | ||
| | | | ||
* Hypertension and hypokalemia | * [[Hypertension]] and [[hypokalemia]] | ||
* Virilization | * [[Virilization]] | ||
|- | |- | ||
|3β-Hydroxysteroid Dehydrogenase | |3β-Hydroxysteroid Dehydrogenase | ||
|Increased: | |Increased: | ||
* DHEA | * [[DHEA]] | ||
* 17- | * [[17-hydroxypregnenolone]] | ||
* Pregnenolone | * [[Pregnenolone]] | ||
Decreased: | Decreased: | ||
* Cortisol | * [[Cortisol]] | ||
* Aldosterone | * [[Aldosterone]] | ||
| | | | ||
* Low testosterone levels | * Low [[testosterone]] levels | ||
| | | | ||
* Salt-wasting adrenal crises in infancy | * Salt-wasting adrenal crises in infancy | ||
* Mild virilization of genetically female infants | * Mild [[virilization]] of genetically female infants | ||
* Undervirilization of genetically male infants, making it the only form of CAH which can cause ambiguous genitalia in both genetic sexes. | * Undervirilization of genetically male infants, making it the only form of [[CAH]] which can cause [[ambiguous genitalia]] in both genetic sexes. | ||
|- | |- | ||
|Polycystic ovary syndrome | |[[Polycystic ovary syndrome ]] | ||
| | | | ||
* High DHEAS and androstenedione levels | * High [[DHEAS]] and [[androstenedione]] levels | ||
| | | | ||
* Low testosterone levels | * Low [[testosterone]] levels | ||
| | | | ||
* Polycystic ovaries in sonography | * Polycystic ovaries in sonography | ||
* Obesity | * [[Obesity]] | ||
* PCOS is the most common cause of hirsutism in women | * [[PCOS]] is the most common cause of [[hirsutism]] in women | ||
* No evidence another diagnosis | * No evidence another diagnosis | ||
|- | |- | ||
|Adrenal tumors | |[[Adrenal tumors]] | ||
| | | | ||
* Variable levels depends on tumor type | * Variable levels depends on [[tumor]] type | ||
| | | | ||
* Low testosterone level | * Low [[testosterone]] level | ||
| | | | ||
* Older age | * Older age | ||
* Rapidly progressive symptoms | * Rapidly progressive symptoms | ||
|- | |- | ||
|Ovarian virilizing tumor | |Ovarian [[virilizing]] tumor | ||
| | | | ||
* Variable levels depends on tumor type | * Variable levels depends on [[tumor]] type | ||
| | | | ||
* Testosterone is high | * [[Testosterone]] is high | ||
| | | | ||
* Older age | * Older age | ||
* Rapidly progressive symptoms | * Rapidly progressive symptoms | ||
|- | |- | ||
|Cushing's syndrome | |[[Cushing's syndrome]] | ||
| | | | ||
* Increase cortisol & metabolites | * Increase [[cortisol]] & metabolites | ||
* Variable other steroids | * Variable other [[steroids]] | ||
| | | | ||
* Variable mineralocorticoid excess | * Variable [[mineralocorticoid]] excess | ||
| | | | ||
* Cushingoid features | * Cushingoid features | ||
|- | |- | ||
|Hyperprolactinemia | |[[Hyperprolactinemia]] | ||
| | | | ||
* Normal levels of most of steroids | * Normal levels of most of [[steroids]] | ||
| | | | ||
* Increased prolactin | * Increased [[prolactin]] | ||
| | | | ||
* Infertility, galactorrea | * [[Infertility]], [[galactorrea]] | ||
|} | |} | ||
== References == | == References == | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 14:09, 1 August 2017
21-hydroxylase deficiency Microchapters |
Differentiating 21-Hydroxylase Deficiency from other Diseases |
Diagnosis |
Treatment |
Case Studies |
21-hydroxylase deficiency differential diagnosis On the Web |
American Roentgen Ray Society Images of 21-hydroxylase deficiency differential diagnosis |
21-hydroxylase deficiency differential diagnosis in the news |
Risk calculators and risk factors for 21-hydroxylase deficiency differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Mehrian Jafarizade, M.D [2]
Overview
21-hydroxylase deficiency must be differentiated from 11-β hydroxylase deficiency, 17-α hydroxylase deficiency, androgen insensitivity syndrome, 3β-Hydroxysteroid Dehydrogenase, polycystic ovarian syndrome, hyperprolactinemia, cushing syndrome, and adrenal tumor.
Differentiating congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other diseases
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency classic type must be differentiated from diseases that cause ambiguous genitalia:[1][2]
Disease name | Laboratory tests | Important clinical findings | |
---|---|---|---|
Increased | Decreased | ||
Classic type of 21-hydroxylase deficiency |
|
| |
11-β hydroxylase deficiency |
|
| |
17-α hydroxylase deficiency |
| ||
3β-Hydroxysteroid Dehydrogenase |
| ||
Gestational hyperandrogenism |
|
|
21-hydroxylase deficiency Non-classic type must be differentiated from diseases that cause virilization and hirsutism in female:[3][2][4]
Disease name | Steroid status | Other laboratory | Important clinical findings |
---|---|---|---|
Non-classic type of 21-hydroxylase deficiency | Increased:
response to ACTH |
|
|
11-β hydroxylase deficiency | Increased:
Decreased: |
|
|
3β-Hydroxysteroid Dehydrogenase | Increased:
Decreased: |
|
|
Polycystic ovary syndrome |
|
|
|
Adrenal tumors |
|
|
|
Ovarian virilizing tumor |
|
|
|
Cushing's syndrome |
|
| |
Hyperprolactinemia |
|
|
References
- ↑ Hughes IA, Nihoul-Fékété C, Thomas B, Cohen-Kettenis PT (2007). "Consequences of the ESPE/LWPES guidelines for diagnosis and treatment of disorders of sex development". Best Pract. Res. Clin. Endocrinol. Metab. 21 (3): 351–65. doi:10.1016/j.beem.2007.06.003. PMID 17875484.
- ↑ 2.0 2.1 White PC, Speiser PW (2000). "Congenital adrenal hyperplasia due to 21-hydroxylase deficiency". Endocr. Rev. 21 (3): 245–91. doi:10.1210/edrv.21.3.0398. PMID 10857554.
- ↑ Hohl A, Ronsoni MF, Oliveira M (2014). "Hirsutism: diagnosis and treatment". Arq Bras Endocrinol Metabol. 58 (2): 97–107. PMID 24830586. Vancouver style error: initials (help)
- ↑ Melmed, Shlomo (2016). Williams textbook of endocrinology. Philadelphia, PA: Elsevier. ISBN 978-0323297387.=